Showing results (1541-1550 of 2,360) with videos related to
Sort By:
Pageof 236
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 22, 2020
[USEFULNESS OF VIVID (VISUALIZATION OF VARIOUS INTEGRATION WITH DIFFUSION) ON COGNITIVE FUSION PROSTATE BIOPSY]Akira Ohtsu, Nobuaki Shimizu, Hiroyuki Horikoshi, et al.Nuclear Medicine Communications|September 21, 2020
131I-6β-iodomethyl-19-norcholesterol adrenal scintigraphy as an alternative to adrenal venous sampling in differentiating aldosterone-producing adenoma from bilateral idiopathic hyperaldosteronismAtsushi Saiga, Hajime Yokota, Hidekazu Nagano, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1987
[Combination chemotherapy with cis-platinum, vinblastine and adriamycin for non-small cell lung cancer]Y Ito, M Ogawa, N Horikoshi, et al.Investigational New Drugs|July 1, 1989
Phase I and pharmacokinetic study of SM-5887, a new anthracycline derivativeK Inoue, M Ogawa, N Horikoshi, et al.Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|May 6, 2021
Autonomic cardiogastric neural interaction after pulmonary vein isolation in patients with atrial fibrillationShinya Yamada, Takashi Kaneshiro, Naoko Hijioka, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1992
[High-dose thio-TEPA with escalating doses of epirubicin and autologous hematopoietic stem cell transplant for refractory cancers]T Mukaiyama, M Ogawa, N Horikoshi, et al.General Thoracic and Cardiovascular Surgery|August 6, 2018
Repeat surgical intervention after aortic repair for acute Stanford type A dissectionTadashi Kitamura, Shinzo Torii, Kensuke Kobayashi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1988
[Phase I study of SM-5887, a new anthracycline derivative]K Inoue, M Ogawa, N Horikoshi, et al.Biochemical and Biophysical Research Communications|April 13, 1999
Distribution and characterization of immunoreactive prolactin-releasing peptide (PrRP) in rat tissue and plasmaH Matsumoto, Y Murakami, Y Horikoshi, et al.Cancer|February 22, 2002
Irinotecan hydrochloride for the treatment of recurrent and refractory non-Hodgkin lymphoma: a single institution experienceKatsuki Sugiyama, Ken Omachi, Keiichi Fujiwara, et al.Pageof 236